EUROIMPLANTAS - Company finances
|
EUR
|
2018
From: 2018-01-01
To: 2018-12-31
|
2019
From: 2019-01-01
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|---|
|
Financial data
|
||||||||
| Sales revenue | 41,525 | 69,775 | 153,042 | 132,054 | 205,405 | 147,982 | 156,550 | 111,971 |
| Profit before tax | 7,490 | 42,095 | 125,172 | 2,614 | 134,066 | 27,236 | 62,347 | 24,169 |
| Net profit | 7,110 | 39,985 | 118,910 | 2,483 | 127,358 | 25,874 | 59,230 | 22,719 |
| Equity | 42,225 | 82,212 | 146,122 | 22,605 | 149,963 | 118,416 | 177,645 | 150,364 |
| Liabilities | 375 | 5,836 | 9,556 | 79,832 | 89,313 | 80,238 | 40,723 | 38,571 |
| Non-current assets | 1 | 1 | 1 | 10,501 | 9,451 | 8,401 | 7,350 | 6,300 |
| Current assets | 42,599 | 88,047 | 155,677 | 91,936 | 229,034 | 189,872 | 210,489 | 182,085 |
| Total assets | 42,600 | 88,048 | 155,678 | 102,437 | 238,485 | 198,273 | 217,839 | 188,385 |
|
Taxes paid
|
||||||||
| STI taxes | - | - | - | - | - | 16,175 | 708 | 10,928 |
|
Financial indicators
|
||||||||
| Revenue change y/y | -57.3% | +68.0% | +119.3% | -13.7% | +55.5% | -28.0% | +5.8% | -28.5% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 16.7% | 45.4% | 76.4% | 2.4% | 53.4% | 13.0% | 27.2% | 12.1% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | 16.8% | 48.6% | 81.4% | 11.0% | 84.9% | 21.9% | 33.3% | 15.1% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | 17.1% | 57.3% | 77.7% | 1.9% | 62.0% | 17.5% | 37.8% | 20.3% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | 18.0% | 60.3% | 81.8% | 2.0% | 65.3% | 18.4% | 39.8% | 21.6% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | 0.0 | 0.1 | 0.1 | 3.5 | 0.6 | 0.7 | 0.2 | 0.3 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 20,763 | 34,888 | 76,521 | 66,027 | 107,166 | 147,982 | 156,550 | 111,971 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
EUROIMPLANTAS - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2026-06-16 | 2026-07-08 | 0.39 |
| 2026-05-17 | 2026-06-08 | 0.39 |
| 2026-05-03 | 2026-05-10 | 0.39 |
| 2026-04-24 | 2026-04-29 | 0.39 |
| 2026-03-27 | 2026-03-27 | 140.03 |
| 2026-03-17 | 2026-03-25 | 140.03 |
| 2025-11-20 | 2025-12-03 | 0.09 |
| 2025-10-16 | 2025-11-16 | 0.09 |
| 2025-09-07 | 2025-10-08 | 0.09 |
| 2025-08-31 | 2025-09-03 | 0.09 |
| 2025-07-16 | 2025-08-29 | 0.09 |
| 2025-06-17 | 2025-07-14 | 0.09 |
| 2025-06-08 | 2025-06-09 | 0.09 |
| 2025-05-16 | 2025-06-04 | 0.09 |
| 2025-05-04 | 2025-05-07 | 0.09 |
| 2025-04-30 | 2025-04-30 | 0.03 |
| 2025-04-24 | 2025-04-29 | 0.09 |
| 2025-04-16 | 2025-04-23 | 0.03 |
| 2025-03-18 | 2025-04-10 | 0.03 |
| 2025-02-18 | 2025-03-12 | 0.03 |
| 2025-01-22 | 2025-02-16 | 0.03 |
| 2025-01-16 | 2025-01-19 | 47.21 |
| 2024-09-17 | 2024-10-15 | 0.10 |
| 2024-08-19 | 2024-09-11 | 0.10 |
| 2024-07-24 | 2024-08-07 | 0.10 |
| 2024-06-18 | 2024-06-18 | 112.13 |
| 2024-05-16 | 2024-05-19 | 112.25 |
| 2024-04-23 | 2024-05-15 | 0.12 |
| 2024-02-19 | 2024-03-13 | 0.30 |
| 2024-01-23 | 2024-02-08 | 0.30 |
| 2024-01-16 | 2024-01-18 | 101.93 |
| 2023-11-16 | 2023-11-20 | 102.18 |
| 2023-10-20 | 2023-11-15 | 0.25 |
| 2023-10-17 | 2023-10-19 | 102.18 |
| 2023-09-18 | 2023-10-16 | 0.25 |
| 2023-08-17 | 2023-09-14 | 0.25 |
| 2023-07-24 | 2023-08-09 | 0.25 |
| 2023-07-18 | 2023-07-23 | 0.20 |
| 2023-06-16 | 2023-07-11 | 0.20 |
| 2023-05-17 | 2023-06-12 | 0.20 |
| 2023-05-16 | 2023-05-16 | 80.68 |
| 2023-05-02 | 2023-05-15 | 0.20 |
| 2023-04-18 | 2023-04-28 | 0.20 |
| 2023-02-17 | 2023-04-06 | 0.20 |
| 2023-02-06 | 2023-02-08 | 0.20 |
| 2023-01-23 | 2023-02-03 | 0.20 |
| 2022-12-16 | 2022-12-19 | 135.29 |
| 2022-11-21 | 2022-12-15 | 0.10 |
| 2022-11-17 | 2022-11-18 | 0.10 |
| 2022-10-31 | 2022-11-10 | 0.10 |
| 2022-08-23 | 2022-09-15 | 0.12 |
| 2022-07-25 | 2022-08-04 | 0.12 |
| 2022-05-17 | 2022-05-18 | 129.88 |
| 2022-02-17 | 2022-03-02 | 5.33 |
EUROIMPLANTAS - VMI tax arrears
The company had no tax arrears (debts) to the State Tax Inspectorate
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
EUROIMPLANTAS, UAB (code 300039159) is a Private Limited Liability Company operating in the wholesale of pharmaceutical and medical goods. In 2025, the company generated revenue of €112.0K and net profit of €22.7K, with a profit margin of 20.3%. Revenue declined by 28.5% year on year after €156.6K in 2024 and was also below the €148.0K recorded in 2023. Profitability softened from the stronger 2024 result, when net profit reached €59.2K and the margin was 37.8%, but the business remained profitable in 2025. Over the three-year period, equity increased from €118.4K in 2023 to €177.6K in 2024 and then eased to €150.4K in 2025, while liabilities fell from €80.2K to €38.6K. Total assets stood at €188.4K at the end of 2025, with short-term assets making up most of the balance sheet. Latest ratios indicate ROE of 15.1%, ROA of 12.1%, debt-to-equity of 0.26, and asset turnover of 0.59x. Revenue per employee was €112.0K and profit per employee €22.7K.